175 related articles for article (PubMed ID: 29893334)
21. Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zhang R; Huang YS; Hua ZM; Yun CT; Zeng RF; Long JT
Gene; 2013 Oct; 528(2):335-42. PubMed ID: 23892089
[TBL] [Abstract][Full Text] [Related]
22. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck.
Li C; Hu Z; Lu J; Liu Z; Wang LE; El-Naggar AK; Sturgis EM; Spitz MR; Wei Q
Cancer; 2007 Aug; 110(4):867-75. PubMed ID: 17614107
[TBL] [Abstract][Full Text] [Related]
24. DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.
Farnebo L; Stjernström A; Fredrikson M; Ansell A; Garvin S; Thunell LK
DNA Repair (Amst); 2015 Jul; 31():64-72. PubMed ID: 26001739
[TBL] [Abstract][Full Text] [Related]
25. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.
Liu H; Gao F; Dahlstrom KR; Li G; Sturgis EM; Zevallos JP; Wei Q; Liu Z
Tumour Biol; 2016 Jun; 37(6):8057-66. PubMed ID: 26711789
[TBL] [Abstract][Full Text] [Related]
26. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism.
Khan SG; Metter EJ; Tarone RE; Bohr VA; Grossman L; Hedayati M; Bale SJ; Emmert S; Kraemer KH
Carcinogenesis; 2000 Oct; 21(10):1821-5. PubMed ID: 11023539
[TBL] [Abstract][Full Text] [Related]
27. XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck.
Sturgis EM; Castillo EJ; Li L; Eicher SA; Strom SS; Spitz MR; Wei Q
Oral Oncol; 2002 Jul; 38(5):475-7. PubMed ID: 12110342
[TBL] [Abstract][Full Text] [Related]
28. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
[TBL] [Abstract][Full Text] [Related]
29. Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India.
Kumar A; Pant MC; Singh HS; Khandelwal S
Tumour Biol; 2012 Feb; 33(1):111-9. PubMed ID: 22081374
[TBL] [Abstract][Full Text] [Related]
30. XPC Polymorphism and Risk for Lung Cancer in North Indian Patients Treated with Platinum Based Chemotherapy and Its Association with Clinical Outcomes.
Lawania S; Singh N; Behera D; Sharma S
Pathol Oncol Res; 2018 Apr; 24(2):353-366. PubMed ID: 28540485
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of DNA repair genes and risk of squamous cell carcinoma of the head and neck in young adults.
Kostrzewska-Poczekaj M; Gawęcki W; Illmer J; Rydzanicz M; Gajecka M; Szyfter W; Szyfter K
Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):271-6. PubMed ID: 22427030
[TBL] [Abstract][Full Text] [Related]
32. Association of XPC Gene Polymorphisms with Prostate Cancer Risk.
Kahnamouei SA; Narouie B; Sotoudeh M; Mollakouchekian MJ; Simforoosh N; Ziaee SA; Samzadeh M; Afshari M; Jamaldini SH; Imeni M; Hasanzad M
Clin Lab; 2016; 62(6):1009-15. PubMed ID: 27468562
[TBL] [Abstract][Full Text] [Related]
33. New polymorphisms of Xeroderma Pigmentosum DNA repair genes in myelodysplastic syndrome.
Santiago SP; Junior HLR; de Sousa JC; de Paula Borges D; de Oliveira RTG; Farias IR; Costa MB; Maia ARS; da Nóbrega Ito M; Magalhães SMM; Pinheiro RF
Leuk Res; 2017 Jul; 58():73-82. PubMed ID: 28472728
[TBL] [Abstract][Full Text] [Related]
34. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China.
Dong Z; Guo W; Zhou R; Wan L; Li Y; Wang N; Kuang G; Wang S
J Clin Gastroenterol; 2008 Sep; 42(8):910-5. PubMed ID: 18645534
[TBL] [Abstract][Full Text] [Related]
36. XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.
Lopes-Aguiar L; Costa EF; Nogueira GA; Lima TR; Visacri MB; Pincinato EC; Calonga L; Mariano FV; de Almeida Milani Altemani AM; Altemani JM; Coutinho-Camillo CM; Ribeiro Alves MA; Moriel P; Ramos CD; Chone CT; Lima CS
Oncotarget; 2017 Mar; 8(10):16190-16201. PubMed ID: 26918827
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
38. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
39. Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck.
Yu H; Liu Z; Huang YJ; Yin M; Wang LE; Wei Q
PLoS One; 2012; 7(7):e41853. PubMed ID: 22848636
[TBL] [Abstract][Full Text] [Related]
40. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
